Cristers, a French pharmaceutical company, has selected Adents Prodigi cloud serialization solution to ensure compliance with the EU Falsified Medicines Directive (FMD) and provide beyond-compliance ROI. Jointly developed with Microsoft and powered by Azure, Adents Prodigi allows for secure data exchange and helps leverage the power of serialisation data to improve business practices.
 
Cristers markets generic and OTC products withmarketing authorizations for more than 400 products.
 
Cristers sought a means of enabling easy exchange of serialization data with its supply chain partners, including contract manufacturers and logistics providers. Additionally, Cristers wanted a solution that would aid in the onboarding of more than 30 European partners – including CMOs, vendors and third-party logistics providers – and facilitate connection with a diverse set of Levels 3 & 4 serialization solutions.
 
The Adents Prodigi cloud-based Level 4 traceability solution centrally manages regulatory requirements, provides an onboarding process to connect multiple trading partners, and facilitates business improvements by enabling companies to utilize the massive amounts of data generated during the serialization and track & trace process.
 
“Adents Prodigi solution was the best native cloud Level 4 solution that offers us scalable and cost-efficient IT architecture in addition to a quick and easy partners on-boarding,” said Hervé Abou, head Pharmacist of Cristers.
 
“Our pre-qualified software saves time during the validation phase, provides ultimate data security, and offers tremendous advanced analytics capabilities – enabling companies to move beyond compliance to improve business practices,” said Christophe Devins, founder and chief executive officer of Adents.